High-flow arteriovenous fistula and hemodynamic consequences at 1year after kidney transplantation

Nicolas Keller1, Alexandra Monnier2, Sophie Caillard1

  • 1Department of Nephrology and Transplantation, Nouvel Hôpital Civil, Strasbourg, France.

Seminars in Dialysis
|November 2, 2021
PubMed

Insights

Kidney transplant patients with high-flow arteriovenous fistulas showed larger left ventricular diameters. While not pathological, these findings highlight potential cardiovascular impacts of high-flow fistulas post-transplant.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation

Background:

  • Cardiovascular complications are a concern after kidney transplantation.
  • Arteriovenous fistulas (AVFs) are crucial for hemodialysis access.
  • Limited data exist on the cardiovascular effects of AVF flow rates post-transplant.

Purpose of the Study:

  • To investigate the cardiovascular impact of arteriovenous fistula flow in kidney transplant recipients.
  • To compare cardiac parameters based on different fistula flow categories.

Main Methods:

  • Prospective, single-center cohort study of 49 kidney transplant patients with functional fistulas at 1 year.
  • Clinical work-up, biological analysis, Doppler ultrasonography for fistula flow, and echocardiography.
  • Comparison of echocardiography parameters between normal-flow and high-flow fistula groups (absolute and relative).

Main Results:

  • High-flow fistulas were present in 69% of patients.
  • Significantly larger left ventricular end-diastolic and systolic diameters were observed in high-flow fistula patients compared to normal-flow.
  • These differences were also significant between absolute and relative high-flow subgroups.

Conclusions:

  • High-flow arteriovenous fistulas in kidney transplant recipients are associated with increased left ventricular dimensions.
  • These observed increases in ventricular diameters were statistically significant but not considered pathological.
  • Further monitoring of cardiovascular parameters in relation to fistula flow is warranted.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
420
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
189
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
95
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
101
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
190
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
202